 Attention Deficit Disorder with Hyperactivity
"Attention Deficit Disorder with Hyperactivity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-IV)
| Descriptor ID |
D001289
|
| MeSH Number(s) |
F03.550.150.150
|
| Concept/Terms |
Attention Deficit Disorder with Hyperactivity- Attention Deficit Disorder with Hyperactivity
- Hyperkinetic Syndrome
- Syndromes, Hyperkinetic
- Attention Deficit Hyperactivity Disorders
- Attention Deficit-Hyperactivity Disorder
- Attention Deficit-Hyperactivity Disorders
- Deficit-Hyperactivity Disorder, Attention
- Deficit-Hyperactivity Disorders, Attention
- Disorder, Attention Deficit-Hyperactivity
- Disorders, Attention Deficit-Hyperactivity
- Attention Deficit Disorders with Hyperactivity
- Attention Deficit Hyperactivity Disorder
Attention Deficit Disorder- Attention Deficit Disorder
- Attention Deficit Disorders
- Deficit Disorder, Attention
- Deficit Disorders, Attention
- Disorder, Attention Deficit
- Disorders, Attention Deficit
|
Below are MeSH descriptors whose meaning is more general than "Attention Deficit Disorder with Hyperactivity".
Below are MeSH descriptors whose meaning is more specific than "Attention Deficit Disorder with Hyperactivity".
This graph shows the total number of publications written about "Attention Deficit Disorder with Hyperactivity" by people in UAMS Profiles by year, and whether "Attention Deficit Disorder with Hyperactivity" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 1 | 0 | 1 | | 2023 | 5 | 0 | 5 | | 2022 | 3 | 0 | 3 | | 2021 | 6 | 0 | 6 | | 2020 | 6 | 1 | 7 | | 2019 | 3 | 0 | 3 | | 2018 | 5 | 1 | 6 | | 2017 | 3 | 0 | 3 | | 2016 | 7 | 0 | 7 | | 2015 | 2 | 1 | 3 | | 2014 | 6 | 1 | 7 | | 2013 | 2 | 1 | 3 | | 2012 | 1 | 1 | 2 | | 2011 | 6 | 0 | 6 | | 2010 | 3 | 1 | 4 | | 2009 | 2 | 1 | 3 | | 2008 | 3 | 0 | 3 | | 2007 | 5 | 1 | 6 | | 2006 | 6 | 0 | 6 | | 2005 | 6 | 1 | 7 | | 2004 | 4 | 0 | 4 | | 2003 | 2 | 0 | 2 | | 2002 | 5 | 1 | 6 | | 2001 | 1 | 0 | 1 | | 2000 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 1998 | 2 | 1 | 3 | | 1997 | 0 | 1 | 1 | | 1995 | 0 | 1 | 1 | | 1994 | 2 | 1 | 3 | | 1992 | 1 | 1 | 2 | | 1991 | 1 | 0 | 1 | | 1990 | 3 | 0 | 3 | | 1989 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Attention Deficit Disorder with Hyperactivity" by people in Profiles over the past ten years.
-
Baweja R, Faraone SV, Childress AC, Weiss MD, Loo SK, Wilens TE, Waxmonsky JG. From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care. J Child Adolesc Psychopharmacol. 2024 05; 34(4):167-182.
-
Koonce RM, Martin BC. The association between suspected long-COVID and stimulant prescribing in the United States. Psychiatry Res. 2024 Jan; 331:115686.
-
Kiani B, Hadianfard H, Weiss MD, Dehbozorgi S. Receiver operating characteristic curve analysis of the Weiss Functional Impairment Rating Scale-Parent Report for screening children with ADHD: Looking beyond symptoms in ADHD diagnosis. Early Interv Psychiatry. 2024 Jun; 18(6):431-438.
-
Stott J, Coleman E, Hamilton A, Blackwell J, Ball HL. Exploring the Longitudinal Relationship Between Short Sleep Duration, Temperament and Attention Deficit Hyperactivity Disorder Symptoms in a Biethnic Population of Children Aged Between 6 and 61 Months: A Born in Bradford Study. J Atten Disord. 2023 07; 27(9):929-938.
-
Pujalte GGA, Narducci DM, Smith MS, King R, Logan K, Callender SS, Liebman CA, Kane SF, Israel MP, Wolf SF, Nuti R, Khodaee M. Athletes With Attention-Deficit/Hyperactivity Disorder: Position Statement of the American Medical Society for Sports Medicine. Clin J Sport Med. 2023 05 01; 33(3):195-208.
-
Zhang X, Berridge MS, Apana SM, Slikker W, Paule MG, Talpos J. Discontinuation of methylphenidate after long-term exposure in nonhuman primates. Neurotoxicol Teratol. 2023 May-Jun; 97:107173.
-
Liachenko S, Chelonis J, Paule MG, Li M, Sadovova N, Talpos JC. The effects of long-term methylphenidate administration and withdrawal on progressive ratio responding and T2 MRI in the male rhesus monkey. Neurotoxicol Teratol. 2022 Sep-Oct; 93:107119.
-
Di Lonardo Burr SM, LeFevre JA, Arnold LE, Epstein JN, Hinshaw SP, Molina BSG, Hechtman L, Hoza B, Jensen PS, Vitiello B, Pelham WE, Howard AL. Paths to postsecondary education enrollment among adolescents with and without childhood attention-deficit/hyperactivity disorder (ADHD): A longitudinal analysis of symptom and academic trajectories. Child Dev. 2022 09; 93(5):e563-e580.
-
Weiss MD, Stein MA. Measurement Informed Care in Attention-Deficit/Hyperactivity Disorder (ADHD). Child Adolesc Psychiatr Clin N Am. 2022 07; 31(3):363-372.
-
Das A, Padala KP, Padala PR. Understanding Associations Between Attention-Deficit/Hyperactivity Disorder and Traumatic Brain Injury. JAMA Pediatr. 2022 01 01; 176(1):101-102.
-
Bilder DA, Arnold GL, Dimmock D, Grant ML, Janzen D, Longo N, Nguyen-Driver M, Jurecki E, Merilainen M, Amato G, Waisbren S. Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria. Am J Med Genet A. 2022 03; 188(3):768-778.
-
Fietsam AC, Tucker JR, Kamath MS, Huang-Pollock C, Wang Z, Neely KA. Manual dexterity and strength and in young adults with and without Attention-Deficit/Hyperactivity Disorder (ADHD). Neurosci Lett. 2022 01 01; 766:136349.
-
Weiss MD, Surman C, Khullar A, Owens J, He E, Cataldo M, Donnelly G. Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up. J Child Adolesc Psychopharmacol. 2021 11; 31(9):623-630.
-
Weiss MD, Cutler AJ, Kollins SH, Donnelly GAE. Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension. J Child Adolesc Psychopharmacol. 2021 11; 31(9):610-622.
-
Sibley MH, Arnold LE, Swanson JM, Hechtman LT, Kennedy TM, Owens E, Molina BSG, Jensen PS, Hinshaw SP, Roy A, Chronis-Tuscano A, Newcorn JH, Rohde LA. Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD. Am J Psychiatry. 2022 Feb; 179(2):142-151.
-
Weiss MD, Surman C, Khullar A, He E, Cataldo M, Donnelly G. Effect of a Multi-Layer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adults with ADHD: A Randomized, Double-Blind, Forced-Dose, Placebo-Controlled Trial Followed by a 6-month Open-Label Extension. CNS Drugs. 2021 06; 35(6):667-679.
-
Merzon E, Weiss MD, Cortese S, Rotem A, Schneider T, Craig SG, Vinker S, Golan Cohen A, Green I, Ashkenazi S, Weizman A, Manor I. The Association between ADHD and the Severity of COVID-19 Infection. J Atten Disord. 2022 02; 26(4):491-501.
-
Childress AC, Beltran N, Supnet C, Weiss MD. Reviewing the role of emerging therapies in the ADHD armamentarium. Expert Opin Emerg Drugs. 2021 03; 26(1):1-16.
-
Craig SG, Bondi BC, O'Donnell KA, Pepler DJ, Weiss MD. ADHD and Exposure to Maltreatment in Children and Youth: a Systematic Review of the Past 10?Years. Curr Psychiatry Rep. 2020 11 08; 22(12):79.
-
Addicott MA, Pearson JM, Schechter JC, Sapyta JJ, Weiss MD, Kollins SH. Attention-deficit/hyperactivity disorder and the explore/exploit trade-off. Neuropsychopharmacology. 2021 02; 46(3):614-621.
-
Soto PL, Hiranita T. Effects of benztropine analogs on delay discounting in rats. Psychopharmacology (Berl). 2020 Dec; 237(12):3783-3794.
-
Atallah M, Cooper B, Mu?oz RF, Paul SM, Anguera J, Levine JD, Hammer M, Wright F, Chen LM, Melisko M, Conley YP, Miaskowski C, Dunn LB. Psychological Symptoms and Stress Are Associated With Decrements in Attentional Function in Cancer Patients Undergoing Chemotherapy. Cancer Nurs. 2020 Sep/Oct; 43(5):402-410.
-
Shih P, Huang CC, Pan SC, Chiang TL, Guo YL. Hyperactivity disorder in children related to traffic-based air pollution during pregnancy. Environ Res. 2020 09; 188:109588.
-
Weiss MD, Childress AC, Donnelly GAE. Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension. J Atten Disord. 2021 08; 25(10):1417-1428.
-
Greenhill LL, Swanson JM, Hechtman L, Waxmonsky J, Arnold LE, Molina BSG, Hinshaw SP, Jensen PS, Abikoff HB, Wigal T, Stehli A, Howard A, Hermanussen M, Hanc T. Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2020 08; 59(8):978-989.
-
Addicott MA, Schechter JC, Sapyta JJ, Selig JP, Kollins SH, Weiss MD. Methylphenidate increases willingness to perform effort in adults with ADHD. Pharmacol Biochem Behav. 2019 08; 183:14-21.
-
Shabason EK, Brodsky C, Baran J, Isaac L, Minturn JE, Ginsberg JP, Hobbie W, Fisher M, Blum N, Hocking MC. Clinical diagnosis of attention-deficit/hyperactivity disorder in survivors of pediatric brain tumors. J Neurooncol. 2019 Jun; 143(2):305-312.
-
Mitchell JT, Sibley MH, Hinshaw SP, Kennedy TM, Chronis-Tuscano A, Arnold LE, Swanson JM, Hechtman LT, Molina BSG, Caye A, Tamm L, Owens EB, Roy A, Weisner TS, Murray DW, Jensen PS. A Qualitative Analysis of Contextual Factors Relevant to Suspected Late-Onset ADHD. J Atten Disord. 2021 03; 25(5):724-735.
-
Compton WM, Han B, Blanco C, Jones CM. Misuse of Immediate-Release Stimulants: Response to Diller. Am J Psychiatry. 2019 01 01; 176(1):77-78.
-
Kiani B, Hadianfard H, Weiss MD. Descriptive and psychometric properties of the Persian version of the Weiss functional impairment rating scale: parent report form in Iranian children. Health Qual Life Outcomes. 2018 Dec 07; 16(1):225.
-
Weiss MD, McBride NM, Craig S, Jensen P. Conceptual review of measuring functional impairment: findings from the Weiss Functional Impairment Rating Scale. Evid Based Ment Health. 2018 Nov; 21(4):155-164.
-
Veerapandiyan A, Oh D, Kornitzer J. Distal 1q21.1 and proximal 1q21.2 microduplication in a child with attention-deficit hyperactivity disorder. Acta Neurol Belg. 2019 Jun; 119(2):289-290.
-
Weiss M, Childress A, Mattingly G, Nordbrock E, Kupper RJ, Adjei AL. Relationship Between Symptomatic and Functional Improvement and Remission in a Treatment Response to Stimulant Trial. J Child Adolesc Psychopharmacol. 2018 10; 28(8):521-529.
-
Rucker JC, Phillips PH. Efferent Vision Therapy. J Neuroophthalmol. 2018 Jun; 38(2):230-236.
-
Jensen PS, Weisner T, Hinshaw SP. Introduction: Just Say No? New Insights About Change Versus Constancy in Substance Use Behavioral Decisions in Youth With and Without ADHD. J Atten Disord. 2018 07; 22(9_suppl):3S-9S.
-
Froehlich TE, Becker SP, Nick TG, Brinkman WB, Stein MA, Peugh J, Epstein JN. Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial. J Clin Psychiatry. 2018 Mar/Apr; 79(2).
-
Weiss MD, Surman CBH, Elbe D. Stimulant 'rapid metabolizers': wrong label, real phenomena. Atten Defic Hyperact Disord. 2018 Jun; 10(2):113-118.
-
Swanson JM, Wigal T, Jensen PS, Mitchell JT, Weisner TS, Murray D, Arnold LE, Hechtman L, Molina BSG, Owens EB, Hinshaw SP, Belendiuk K, Howard A, Wigal SB, Sorensen P, Stehli A. The Qualitative Interview Study of Persistent and Nonpersistent Substance Use in the MTA: Sample Characteristics, Frequent Use, and Reasons for Use. J Atten Disord. 2018 07; 22(9_suppl):21S-37S.
-
Sweitzer MM, Kollins SH, Kozink RV, Hallyburton M, English J, Addicott MA, Oliver JA, McClernon FJ. ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge. Neuropsychopharmacology. 2018 03; 43(4):851-858.
-
Weisner TS, Murray DW, Jensen PS, Mitchell JT, Swanson JM, Hinshaw SP, Wells K, Hechtman L, Molina BSG, Arnold LE, Sorensen P, Stehli A. Follow-Up of Young Adults With ADHD in the MTA: Design and Methods for Qualitative Interviews. J Atten Disord. 2018 07; 22(9_suppl):10S-20S.
-
Jensen PS, Yuki K, Murray D, Mitchell JT, Weisner T, Hinshaw S, Molina B, Swanson J, Arnold LE, Hechtman L, Wells K. Turning Points in the Lives of Youth of With/Without ADHD: Are They Linked to Changes in Substance Use? J Atten Disord. 2018 07; 22(9_suppl):38S-48S.
-
Williamson D, Johnston C, Noyes A, Stewart K, Weiss MD. Attention-Deficit/Hyperactivity Disorder Symptoms in Mothers and Fathers: Family Level Interactions in Relation to Parenting. J Abnorm Child Psychol. 2017 04; 45(3):485-500.
-
Swanson JM, Arnold LE, Molina BSG, Sibley MH, Hechtman LT, Hinshaw SP, Abikoff HB, Stehli A, Owens EB, Mitchell JT, Nichols Q, Howard A, Greenhill LL, Hoza B, Newcorn JH, Jensen PS, Vitiello B, Wigal T, Epstein JN, Tamm L, Lakes KD, Waxmonsky J, Lerner M, Etcovitch J, Murray DW, Muenke M, Acosta MT, Arcos-Burgos M, Pelham WE, Kraemer HC. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression. J Child Psychol Psychiatry. 2017 Jun; 58(6):663-678.
-
Mitchell JT, Weisner TS, Jensen PS, Murray DW, Molina BSG, Arnold LE, Hechtman L, Swanson JM, Hinshaw SP, Victor EC, Kollins SH, Wells KC, Belendiuk KA, Blonde A, Nguyen C, Ambriz L, Nguyen JL. How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning. J Atten Disord. 2018 07; 22(9_suppl):49S-60S.
-
Craig SG, Weiss MD, Hudec KL, Gibbins C. The Functional Impact of Sleep Disorders in Children With ADHD. J Atten Disord. 2020 02; 24(4):499-508.
-
Takeda T, Tsuji Y, Kanazawa J, Sakai T, Weiss MD. Psychometric properties of the Japanese version of the Weiss Functional Impairment Rating Scale: Self-Report. Atten Defic Hyperact Disord. 2017 Sep; 9(3):169-177.
-
Dougherty DM, Olvera RL, Acheson A, Hill-Kapturczak N, Ryan SR, Mathias CW. Acute effects of methylphenidate on impulsivity and attentional behavior among adolescents comorbid for ADHD and conduct disorder. J Adolesc. 2016 Dec; 53:222-230.
-
Forehand R, Parent J, Sonuga-Barke E, Peisch VD, Long N, Abikoff HB. Which Type of Parent Training Works Best for Preschoolers with Comorbid ADHD and ODD? A Secondary Analysis of a Randomized Controlled Trial Comparing Generic and Specialized Programs. J Abnorm Child Psychol. 2016 11; 44(8):1503-1513.
-
Sibley MH, Swanson JM, Arnold LE, Hechtman LT, Owens EB, Stehli A, Abikoff H, Hinshaw SP, Molina BSG, Mitchell JT, Jensen PS, Howard AL, Lakes KD, Pelham WE. Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity. J Child Psychol Psychiatry. 2017 Jun; 58(6):655-662.
-
Hechtman L, Swanson JM, Sibley MH, Stehli A, Owens EB, Mitchell JT, Arnold LE, Molina BS, Hinshaw SP, Jensen PS, Abikoff HB, Perez Algorta G, Howard AL, Hoza B, Etcovitch J, Houssais S, Lakes KD, Nichols JQ. Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results. J Am Acad Child Adolesc Psychiatry. 2016 11; 55(11):945-952.e2.
-
van der Plas E, Dupuis A, Arnold P, Crosbie J, Schachar R. Association of Autism Spectrum Disorder with Obsessive-Compulsive and Attention-Deficit/Hyperactivity Traits and Response Inhibition in a Community Sample. J Autism Dev Disord. 2016 Sep; 46(9):3115-25.
-
Hodgkins P, Lloyd A, Erder MH, Setyawan J, Weiss MD, Sasan? R, Nafees B. Estimating minimal important differences for several scales assessing function and quality of life in patients with attention-deficit/hyperactivity disorder. CNS Spectr. 2017 02; 22(1):31-40.
-
Johnston C, Williamson D, Noyes A, Stewart K, Weiss MD. Parent and Child ADHD Symptoms in Relation to Parental Attitudes and Parenting: Testing the Similarity-Fit Hypothesis. J Clin Child Adolesc Psychol. 2018; 47(sup1):S127-S136.
-
Lasky AK, Weisner TS, Jensen PS, Hinshaw SP, Hechtman L, Arnold LE, W Murray D, Swanson JM. ADHD in context: Young adults' reports of the impact of occupational environment on the manifestation of ADHD. Soc Sci Med. 2016 07; 161:160-8.
-
Tewar S, Auinger P, Braun JM, Lanphear B, Yolton K, Epstein JN, Ehrlich S, Froehlich TE. Association of Bisphenol A exposure and Attention-Deficit/Hyperactivity Disorder in a national sample of U.S. children. Environ Res. 2016 10; 150:112-118.
-
Black BT, Soden SE, Kearns GL, Jones BL. Clinical and Pharmacologic Considerations for Guanfacine Use in Very Young Children. J Child Adolesc Psychopharmacol. 2016 08; 26(6):498-504.
-
Stein MA, Sikirica V, Weiss MD, Robertson B, Lyne A, Newcorn JH. Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial. CNS Drugs. 2015 Nov; 29(11):953-62.
-
Moran LV, Masters GA, Pingali S, Cohen BM, Liebson E, Rajarethinam RP, Ongur D. Prescription stimulant use is associated with earlier onset of psychosis. J Psychiatr Res. 2015 Dec; 71:41-7.
-
Rabie NZ, Bird TM, Magann EF, Hall RW, McKelvey SS. ADHD and developmental speech/language disorders in late preterm, early term and term infants. J Perinatol. 2015 Aug; 35(8):660-4.
-
Wade NG, Vogel DL, Armistead-Jehle P, Meit SS, Heath PJ, Strass HA. Modeling stigma, help-seeking attitudes, and intentions to seek behavioral healthcare in a clinical military sample. Psychiatr Rehabil J. 2015 Jun; 38(2):135-141.
-
Perez Algorta G, Kragh CA, Arnold LE, Molina BSG, Hinshaw SP, Swanson JM, Hechtman L, Copley LM, Lowe M, Jensen PS. Maternal ADHD Symptoms, Personality, and Parenting Stress: Differences Between Mothers of Children With ADHD and Mothers of Comparison Children. J Atten Disord. 2018 11; 22(13):1266-1277.
-
Tarak?ioglu MC, Memik N?, Olgun NN, Aydemir ?, Weiss MD. Turkish validity and reliability study of the Weiss Functional Impairment Rating Scale-Parent Report. Atten Defic Hyperact Disord. 2015 Jun; 7(2):129-39.
-
Frye RE. RASopathies: a window into the molecular mechanisms underlying neurodevelopmental disorders. Dev Med Child Neurol. 2015 Apr; 57(4):315-6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|